Tokyo, June 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062014) titled 'A Multicenter Study of Liver Health and Extrahepatic Diseases in Patients with MASLD' on June 22.
Study Type:
Observational
Primary Sponsor:
Institute - Saga University
Condition:
Condition - Steatotic liver disease
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To clarify the impact of comorbidities and their treatments on survival outcomes in patients with steatotic liver disease
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients who underwent liver biopsy between January 1, 1990 and June 30, 2025.
2) Patients aged younger than 20 years at the time of liver biopsy.
3) Patients with histologically confirmed NAFLD/MASLD.
4) Patients with metabolic dysfunction and/or obesity who did not meet the histological or clinical criteria for NAFLD/MASLD.
Key exclusion criteria - 1) Patients deemed unsuitable for this study by the investigators.
2) Patients who refused to participate in the study.
3) Patients suspected of having other chronic liver diseases.
Target Size - 2000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 09 Month 20 Day
Date of IRB - 2025 Year 10 Month 30 Day
Anticipated trial start date - 2025 Year 10 Month 30 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070963
Disclaimer: Curated by HT Syndication.
